Mark R. Hellberg
Impact in
- Ophthalmology top 2%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Glaucoma and retinal disorders 14
-
- Inflammatory mediators and NSAID effects 6
- Co-authors
- Marsha A. McLaughlin (11 shared papers)Jesse A. May (6 shared papers)Tom R. Dean (3 shared papers)Najam A. Sharif (8 shared papers)Naj A. Sharif (4 shared papers)John C. Liao (3 shared papers)Verney L. Sallee (1 shared paper)Paul W. Zinke (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Bioorganic & Medicinal Chemistry (4 papers)Investigative Ophthalmology & Visual Science (4 papers)Journal of Medicinal Chemistry (3 papers)Journal of Ocular Pharmacology and Therapeutics (3 papers)
- Partner nations
- United StatesNew ZealandCanada
In The Last Decade
Mark R. Hellberg
27 papers receiving 751 citations
Peers
Comparison fields: 5 of 61
- Ophthalmology 405
- Pharmaceutical Science 61
- Organic Chemistry 144
- Pharmacology 58
- Molecular Biology 197
Countries citing papers authored by Mark R. Hellberg
This map shows the geographic impact of Mark R. Hellberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Hellberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Hellberg more than expected).
Fields of papers citing papers by Mark R. Hellberg
This network shows the impact of papers produced by Mark R. Hellberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Hellberg. The network helps show where Mark R. Hellberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark R. Hellberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 101 | |
| 2 | 1997 | 86 | |
| 3 | 2005 | 83 | |
| 4 | 2002 | 67 | |
| 5 | 2003 | 62 | |
| 6 | 2010 | 61 | |
| 7 | 2003 | 43 | |
| 8 | 2007 | 30 | |
| 9 | 2009 | 29 | |
| 10 | 1999 | 26 | |
| 11 | 2010 | 24 | |
| 12 | 2015 | 23 | |
| 13 | 2004 | 21 | |
| 14 | 2015 | 21 | |
| 15 | 2004 | 19 | |
| 16 | 2010 | 19 | |
| 17 | 2002 | 18 | |
| 18 | 2000 | 16 | |
| 19 | 2014 | 14 | |
| 20 | 2002 | 12 |
About Mark R. Hellberg
Mark R. Hellberg is a scholar working on Ophthalmology, Pharmacology, Organic Chemistry, Biochemistry and Molecular Biology, having authored 27 papers that have together received 809 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (14 papers), Synthesis and biological activity (9 papers), Inflammatory mediators and NSAID effects (6 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Receptor Mechanisms and Signaling (2 papers), Organoboron and organosilicon chemistry (1 paper) and Structural and Chemical Analysis of Organic and Inorganic Compounds (1 paper). The work is most often cited by research in Ophthalmology (405 citations), Pharmaceutical Science (61 citations), Organic Chemistry (144 citations), Pharmacology (58 citations) and Molecular Biology (197 citations). Mark R. Hellberg has collaborated with scholars based in United States, New Zealand and Canada. Frequent co-authors include Marsha A. McLaughlin, Jesse A. May, Tom R. Dean, Najam A. Sharif, Naj A. Sharif, John C. Liao, Verney L. Sallee, Paul W. Zinke, Louis M. DeSantis and Peter G. Klimko. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Investigative Ophthalmology & Visual Science, Journal of Medicinal Chemistry and Journal of Ocular Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.